ClinicalTrials.gg
Sign In
Drug

Ceftolozane clinical trials

Also written CXA-101.

studies test it
19
open now
2
in phase 3
5
first study started
2009

Counted the way a researcher would: Ceftolozane with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses ceftolozane is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ceftolozane studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Dec 2014 · ZERBAXA · NDA 206829 (FDA, Drugs@FDA; in a combination)
European Union
18 Sept 2015 · Zerbaxa · EMEA/H/C/003772 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g)
2
Ceftolozane
1

Development codes

CXA-101
2

In one entry with another drug

Given together, or one or the other

Ceftolozane/Tazobactam
12
MK-7625A
3

Studies by the year they started

19 studies that test it; most in 2018 (4)

Studies that test ceftolozane, by start year
YearStudies
20091
20102
20131
20141
20151
20163
20171
20184
20191
20201
20233

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
6
Phase 3
5
Phase 4
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Pyelonephritis
2
Pneumonia, Ventilator-Associated
2
Healthcare-Associated Pneumonia
1
Cystic Fibrosis
1
Urinary Tract Infections
1
Intraabdominal Infections
1
Bronchiectasis
1
Hematologic Neoplasms
1
Pneumonia
1
Burns
1

Who runs them

Industry 11 · Other 8

Merck Sharp & Dohme LLC (6) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (5) · M.D. Anderson Cancer Center (1) · Royal Brisbane and Women's Hospital (1) · Joseph L. Kuti, PharmD (1) · Hartford Hospital (1) · Sunshine Coast Hospital and Health Service (1) · Instituto Nacional de Cancerologia de Mexico (1)

Often tested with

Tested in the same studies.

Ceftolozane, tazobactam drug combination (13) · Metronidazole (3)

Studies

Open first, then newest update. How each study uses ceftolozane is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Codes

What other systems call ceftolozane · ClinicalTrials.gg INT005077

  • MeSH (NLM) C519491ceftolozaneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 37A4IES95QCEFTOLOZANEConfirmed FDA, NLM, Wikidata
  • RxNorm 1597609Confirmed FDA, Wikidata
  • Wikidata Q21011231ceftolozane/tazobactamConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C150024CeftolozaneOne source FDA
  • DrugBank DB09050One source Wikidata

Also registered as ceftolozane sulfate (UNII 7R247U84HY · RxNorm 1597608).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.